Inhibrx Biosciences (INBX) Shares Outstanding (Diluted) (2023 - 2026)
Inhibrx Biosciences' Weighted Average Shares Outstanding (Diluted) was 15.67 million in Q2 2026, up 1.3% from 15.47 million a year earlier.
Powered by 
Analysis
Inhibrx Biosciences (INBX) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends
For FY2025, Weighted Average Shares Outstanding (Diluted) at Inhibrx Biosciences came in at 15.49 million, up 3.4% from FY2024.
- In earlier years, Weighted Average Shares Outstanding (Diluted) was 14.98 million in FY2024 (+27.2%) and 11.78 million in FY2023.
- The Q2 2026 figure marks the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q2 2023.
- The year-over-year growth in Weighted Average Shares Outstanding (Diluted) has ranged between 0.1% (Q3 2025) and 35.7% (Q2 2024) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Inhibrx Biosciences | 1.33 Bn | 760.41 Mn | - | 15.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.67 Mn |
| Mar 31, 2026 | 15.59 Mn |
| Dec 31, 2025 | 15.49 Mn |
| Sep 30, 2025 | 15.48 Mn |
| Jun 30, 2025 | 15.47 Mn |
| Mar 31, 2025 | 15.47 Mn |
| Dec 31, 2024 | 14.98 Mn |
| Sep 30, 2024 | 15.47 Mn |
| Jun 30, 2024 | 14.81 Mn |
| Mar 31, 2024 | 13.64 Mn |
| Dec 31, 2023 | 11.78 Mn |
| Sep 30, 2023 | 11.79 Mn |
| Jun 30, 2023 | 10.91 Mn |
API Access
Inhibrx Biosciences Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=INBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "INBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=INBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();